Every one of those 1 sits in a single category, market-trends. Life Sciences Engagement is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.6 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Interventional MRI
Every one of those 1 sits in a single category, market-trends. Life Sciences Engagement is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.6 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. Interventional MRI appears in 1 tracked Healthcare story from March 6, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Interventional MRI. Shared-story counts are live from our verified record — not editorial picks.
Profound Medical and OptimizeRx reported strong fourth-quarter and full-year 2025 financial results, signaling robust growth in the interventional MRI and life sciences engagement sectors. Both companies demonstrated significant commercial progress, reflecting a broader industry shift toward minimally invasive procedures and data-driven healthcare communication.